Parexel International Corp - Company Profile
Powered by 
All the sales intelligence you need on Parexel International Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Parexel International Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Parexel International Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Parexel International Corp (Parexel) is a biopharmaceutical outsourcing service company. It provides services for managing the biopharmaceutical product lifecycle and the development and commercialization of new medical therapies. The company offers an array of services including clinical trials management, observational studies and patient/disease registries, data management, biostatistical analysis, epidemiology, health economics/outcomes research, pharmacovigilance, medical communications, clinical pharmacology, patient recruitment, clinical supply and drug logistics, post-marketing surveillance, regulatory and product development, and commercialization consulting among others. Parexel caters its products and services to pharmaceutical, biotechnology and medical device industries worldwide. The company offers its services through a network of offices in the Americas, Asia Pacific and EMEA countries. Parexel is headquartered in Raleigh, North Carolina, the US.
Headquarters
United States of America
Address
Suite 1000, 541 Church at North Hills Street, Raleigh, North Carolina, 27609
Website
www.parexel.com
Telephone
1 919 5443170
No of Employees
24,000
Industry
Pharmaceuticals and Healthcare
Parexel International Corp premium industry data and analytics
Products and Services
| Services | Brands |
|---|---|
| Data Management | TrialWorks |
| Clinical Pharmacology | DataLabs EDC |
| Related Medical Advisory | ePRO |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Contracts/Agreements | In October, the company entered into an agreement with Weave Bio to fast-track regulatory submissions using AI. |
| 2025 | Contracts/Agreements | In September, the company entered into an agreement with Weave Bio to speed up market introduction of new therapies. |
| 2025 | Contracts/Agreements | In September, the company entered into an agreement with Paradigm to expand access and efficiency in clinical trials. |
Competitor Comparison
| Key Parameters | Parexel International Corp | IQVIA Holdings Inc | Labcorp Holdings Inc | ICON Plc | Cellero LLC |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | Ireland | United States of America |
| City | Raleigh | Durham | Burlington | Dublin | Lowell |
| State/Province | North Carolina | North Carolina | North Carolina | Dublin | Massachusetts |
| No. of Employees | 24,000 | 94,000 | 71,000 | 40,200 | - |
| Entity Type | Private | Public | Public | Public | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Peyton Howell | Director; Chief Executive Officer | Executive Board | 2022 | - |
| Sheri McCoy | Chairperson | Executive Board | - | - |
| Greg Rush | Chief Financial Officer | Senior Management | 2018 | - |
| Rob Goodwin | Chief Operating Officer | Senior Management | 2025 | - |
| Kushal Gohil | Chief Strategy Officer | Senior Management | 2022 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer